Is Cineplex Stock Finally Worth Buying in 2023?

With recession fears increasing, Cineplex share prices keep falling, but is the beleaguered stock worth buying right now?

| More on:
man is enthralled with a movie in a theater

Source: Getty Images

Cineplex (TSX:CGX) has suffered immensely since the onset of COVID-19. Even before the pandemic forced businesses to shutter down, especially those involving many people in close spaces, the movie theatre giant has been contending with video streaming platforms. Between these two factors and the current market volatility, it seems like Cineplex stock cannot catch a break.

As of this writing, the S&P/TSX Composite Index is down by 5.33% from the same point last year. While the Canadian benchmark index has been on an uptick in the last few weeks, several analysts anticipate a major recession this year due to tightening monetary policies.

A recession seems increasingly likely, with inflation still high and key interest rates rising. These factors can contribute to a major stock market correction, making it less likely for Cineplex stock to become an attractive investment.

Unable to catch a break

As of this writing, Cineplex stock trades for $8.06 per share. At current levels, it is much closer to its 52-week lows than its 52-week highs.

Down by 42.83% from its 52-week high, the $512.11 million market capitalization move theatre and family entertainment company seems like it is floating dead in the water right now. For Cineplex investors, 2023 does not appear to be a year of good news, with the company extending its credit facility by roughly a year.

A recession hitting the market can be another punch in the flurry of hits Cineplex has taken over the years. Debt was the biggest challenge for the company in recent years, and the pandemic erased its top line to balloon its debt to $6 billion in 2022. The company’s estimated debt-servicing cost last year amounted to $120 million as the core business continued losing money.

A few optimistic developments

Despite all its troubles, not everything is doom and gloom with Cineplex stock. The company won a lawsuit against Cineworld, in which the latter was ordered by the court to pay out $1.2 billion to Cineplex for reneging on an acquisition deal in 2020. The settlement amount will help Cineplex cover a major chunk of its debt load.

To make matters better, Avatar: The Way of Water is a major blockbuster that is on track to become one of the highest-grossing movies of all time. Estimates indicate that it will generate roughly $3.5 billion by the end of its theatre run, potentially allowing cinemas to recover much of their pandemic-induced losses.

Cineplex also holds a good deal with Lionsgate studio, which makes it responsible for distributing 11 of the studio giant’s upcoming releases, potentially creating more value for Cineplex investors this year. Mid-2022 also saw Cineplex report a quarterly net profit for the first time since the pandemic struck.

Foolish takeaway

Between the court settlement and improving business in recent weeks, Cineplex stock might see better days this year. However, a recession can undo every positive development, based on how badly it impacts business for the beleaguered theatre giant.

For conservative investors, it might be better to wait on the sidelines and watch how the situation develops. If you have a higher risk tolerance, it might be a good time to allocate some capital you would not mind losing in the stock.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Adam Othman has no position in any of the stocks mentioned. The Motley Fool recommends Cineplex. The Motley Fool has a disclosure policy.

More on Investing

Doctor talking to a patient in the corridor of a hospital.

TFSA: Healthcare Dividend Stocks Are Perfect for Passive Income

Top healthcare dividend stocks like Extendicare Inc. (TSX:EXE) and others can provide huge passive income in your TFSA.

Read more »

TFSA and coins
Tech Stocks

TFSA: Invest in These 2 Stocks for a Legit Chance at $1 Million

Are you interested in building a $1 million portfolio? Invest $20,000 in these two stocks!

Read more »

edit Person using calculator next to charts and graphs

The Top TSX Stock on My Watch List Right Now

Here's why Alimentation Couche-Tard (TSX:ATD) remains a top TSX stock that long-term investors seeking growth and yield will want to…

Read more »

Hourglass projecting a dollar sign as shadow

3 Stocks to Add to Your TFSA ASAP

Given their stable cash flows and solid underlying businesses, these three stocks are excellent additions to your TFSA in this…

Read more »

edit Person using calculator next to charts and graphs
Dividend Stocks

Better Buy: Fortis Stock vs Enbridge

Fortis stock and Enbridge are top dividend stocks on the TSX today. Which stock is better buy for safe dividend…

Read more »

Canadian Dollars
Dividend Stocks

How to Make $1,500 in Passive Income 4 Times a Year

Blue-chip TSX stocks such as Enbridge can enable investors to create game-changing wealth over the long term.

Read more »

Woman has an idea

5 Stocks You Can Confidently Invest $500 in Right Now

Consider putting your surplus cash in these stocks for stellar capital gains.

Read more »

Dividend Stocks

TFSA: How to Easily Turn $10,000 Into $500/Year of Passive Income

You don't need to be a stock market expert to turn $10,000 into a $500 of tax-free passive income. Here's…

Read more »